Suppr超能文献

脊髓髓内肿瘤 174 例的外科治疗。

Surgical treatment of one hundred seventy-four intramedullary spinal cord tumors.

机构信息

Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.

出版信息

Spine (Phila Pa 1976). 2009 Nov 15;34(24):2705-10. doi: 10.1097/BRS.0b013e3181b43484.

Abstract

STUDY DESIGN

A retrospective study of microsurgical treatment of intramedullary spinal cord tumors (IMSCT) was conducted.

OBJECTIVE

In this article we review our experience in dealing with IMSCTs and try to answer the question of the optimum treatment of IMSCTs.

SUMMARY OF BACKGROUND DATA

IMSCTs are commonly seen tumors in intraspinal tumors. The optimum treatment of those tumors is controversial, with the recent advance, the operation of IMSCTs has became safer and total resection of most those tumor is possible.

METHODS

Data from 174 IMSCTs operated on in the last 20 years are analyzed retrospectively by the tumors' anatomic locations, histologic types, symptoms and signs, tumor removal rate, and operative outcomes.

RESULTS

In this group ependymoma was the commonest tumor (48.9%), the second most often seen being astrocytoma (35.6%). On admission 142 patients suffered from motor disturbance and 134 from dysaesthesia. Eighty-eight had sphincter disturbance and 100 spontaneous pain. Total resection of the tumor was possible in 60.9% of patients, subtotal resection in 17.2%, and partial resection in 13.8%. In patients with ependymoma total resection was possible in 92.9% of patients, subtotal in 5.95%, and partial resection in 1.2%. In low grade astrocytoma total resection was possible in 41.1%, subtotal in 35.1%, and partial resection in 23.2%. There were 6 patients with malignant astrocytomata; total resection was possible in 1 patient, subtotal resection in 2, and partial resection in 3.In the other tumors total resection was possible in 63% and subtotal in 14.8%, in 23.2% was partial resection possible. Six months after operation the patient's symptoms and signs were compared with those before operation. Neurologic deficits had improved in 60.4%, there was no change in 36.2% and deterioration in 3.4%. On long-term follow-up there was improvement in 70.2%, no change in 19.5%, deterioration in 4%, tumor recurrence in 6.9%, with 6.3% of patients dying.

CONCLUSION

Most intramedullary spinal cord tumors need operative treatment as early as possible. The outcome of aggressive surgery now is much better than it has been in the past, and the results are acceptable. For malignant tumors and those where total removal has not been possible radiation therapy is necessary.

摘要

研究设计

回顾性分析了显微外科治疗脊髓髓内肿瘤(IMSCT)的病例。

目的

本文旨在总结我们在处理脊髓髓内肿瘤方面的经验,并尝试回答脊髓髓内肿瘤的最佳治疗方法。

背景资料概述

脊髓髓内肿瘤是椎管内肿瘤中常见的肿瘤。这些肿瘤的最佳治疗方法存在争议,随着近年来手术技术的进步,脊髓髓内肿瘤的手术安全性大大提高,大多数肿瘤可实现全切除。

方法

回顾性分析了过去 20 年中 174 例接受手术治疗的脊髓髓内肿瘤患者的临床资料,包括肿瘤的解剖位置、组织学类型、症状和体征、肿瘤切除率和手术结果。

结果

本组中最常见的肿瘤是室管膜瘤(48.9%),其次是星形细胞瘤(35.6%)。入院时,142 例患者有运动障碍,134 例有感觉障碍。88 例有括约肌功能障碍,100 例有自发性疼痛。60.9%的患者肿瘤全切除,17.2%的患者次全切除,13.8%的患者部分切除。在室管膜瘤患者中,92.9%的患者肿瘤全切除,5.95%的患者次全切除,1.2%的患者部分切除。低级别星形细胞瘤患者中,41.1%的患者肿瘤全切除,35.1%的患者次全切除,23.2%的患者部分切除。6 例恶性星形细胞瘤患者中,1 例患者肿瘤全切除,2 例患者次全切除,3 例患者部分切除。其他肿瘤患者中,63%的患者肿瘤全切除,14.8%的患者次全切除,23.2%的患者部分切除。术后 6 个月比较患者的症状和体征,发现 60.4%的患者神经功能缺损改善,36.2%的患者无变化,3.4%的患者恶化。长期随访发现,70.2%的患者病情改善,19.5%的患者无变化,4%的患者病情恶化,6.9%的患者肿瘤复发,6.3%的患者死亡。

结论

大多数脊髓髓内肿瘤需要尽早手术治疗。现在积极的手术治疗效果比过去好得多,结果是可以接受的。对于恶性肿瘤和未能完全切除的肿瘤,需要进行放疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验